Literature DB >> 32250525

Propensity score methods in real-world epidemiology: A practical guide for first-time users.

Yoon Kong Loke1, Katharina Mattishent1.   

Abstract

Real-world epidemiology gives us the unique opportunity to observe large numbers of people, and the actions and events that characterize their encounters with healthcare providers. However, the heterogeneity and sheer diversity of the population and healthcare systems makes it impossible for researchers to compare "like with like" when attempting to draw causal inferences about interventions and outcomes. The critical issue in epidemiological datasets relates to high risk of bias due to confounders that stem from baseline differences between groups. Propensity score (PS) techniques are statistical approaches that have been used to tackle potential imbalance in the comparison groups. The PS is the estimated probability (based on measured baseline covariates) that the patient receives a particular intervention. Patients that share similar PS will most likely have the same distributions of underlying covariates included in the PS. Implementation of PS methods may achieve better balance of covariates, but there is no consensus on the best way of capturing all relevant confounders for incorporation into the PS model. Should covariates be selected by clinical or epidemiological experts, or would data-driven algorithms (machine learning) offer more efficient and reliable methods of estimating PS and controlling for confounding? The PS can be incorporated into the analysis in different ways, each with its own strengths and limitations, and researchers must choose the best fit for their study objectives. PS methods are particularly advantageous in situations where there are large numbers of measured covariates but relatively few outcome events captured in healthcare administrative databases.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  pharmaco-epidemiology

Mesh:

Year:  2020        PMID: 32250525     DOI: 10.1111/dom.13926

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  5 in total

1.  Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study.

Authors:  Romina di Giuseppe; Sandra Plachta-Danielzik; Wolfgang Mohl; Martin Hoffstadt; Thomas Krause; Bernd Bokemeyer; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2021-05-08       Impact factor: 2.571

2.  Effects of Chinese Medicine on the Survival of AIDS Patients Administered Second-Line ART in Rural Areas of China: A Retrospective Cohort Study Based on Real-World Data.

Authors:  Yantao Jin; Miao Zhang; Yanmin Ma; Feng Sang; Pengyu Li; Chunling Yang; Dongli Wang; Huijun Guo; Zhibin Liu; Qianlei Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-27       Impact factor: 2.629

3.  A clinical study to observe the efficacy and safety of Besunyen Detox Tea for constipation.

Authors:  Wenting Fei; Jianjun Zhang; Linyuan Wang; Yi Yang; Yan Chen; Yawen Chen; Ran Tao; Yingli Zhu
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

4.  Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.

Authors:  Yao-Hung Kuo; Ji-An Liang; Guan-Heng Chen; Chia-Chin Li; Chun-Ru Chien
Journal:  Br J Radiol       Date:  2021-04-16       Impact factor: 3.039

5.  Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.

Authors:  Won Euh; Soo Lim; Jin-Wook Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.